185 related articles for article (PubMed ID: 9016889)
1. Treatment of lupus nephritis: a meta-analysis of clinical trials.
Bansal VK; Beto JA
Am J Kidney Dis; 1997 Feb; 29(2):193-9. PubMed ID: 9016889
[TBL] [Abstract][Full Text] [Related]
2. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
Arends S; Berden JH; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M;
Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis.
Felson DT; Anderson J
N Engl J Med; 1984 Dec; 311(24):1528-33. PubMed ID: 6390198
[TBL] [Abstract][Full Text] [Related]
4. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
Grootscholten C; Ligtenberg G; Hagen EC; van den Wall Bake AW; de Glas-Vos JW; Bijl M; Assmann KJ; Bruijn JA; Weening JJ; van Houwelingen HC; Derksen RH; Berden JH;
Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
[TBL] [Abstract][Full Text] [Related]
5. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.
Austin HA; Klippel JH; Balow JE; le Riche NG; Steinberg AD; Plotz PH; Decker JL
N Engl J Med; 1986 Mar; 314(10):614-9. PubMed ID: 3511372
[TBL] [Abstract][Full Text] [Related]
6. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only.
Steinberg AD; Steinberg SC
Arthritis Rheum; 1991 Aug; 34(8):945-50. PubMed ID: 1859488
[TBL] [Abstract][Full Text] [Related]
7. Prednisone monotherapy induced remission in a group of patients with membranous lupus nephritis.
Bitencourt Dias C; Pinheiro CC; Malafronte P; Titan S; Alves de Brito G; Gera Abrão J; Dos Santos Silva V; Toledo Barros R; Woronik V
Clin Nephrol; 2011 Jul; 76(1):57-63. PubMed ID: 21722606
[TBL] [Abstract][Full Text] [Related]
8. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
[TBL] [Abstract][Full Text] [Related]
9. Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial.
Zhang M; Qi C; Zha Y; Chen J; Luo P; Wang L; Sun Z; Wan J; Xing C; Wang S; Jiang G; Sun M; Chen Q; Chen J; Li D; Guan T; Ni Z
Clin Rheumatol; 2019 Mar; 38(3):859-867. PubMed ID: 30426311
[TBL] [Abstract][Full Text] [Related]
10. Treatment for lupus nephritis.
Flanc RS; Roberts MA; Strippoli GF; Chadban SJ; Kerr PG; Atkins RC
Cochrane Database Syst Rev; 2004; (1):CD002922. PubMed ID: 14973998
[TBL] [Abstract][Full Text] [Related]
11. Sequential therapies for proliferative lupus nephritis.
Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive therapy in lupus nephritis.
D'Cruz D; Cuadrado MJ; Mujic F; Tungekar MF; Taub N; Lloyd M; Khamashta MA; Hughes GR
Clin Exp Rheumatol; 1997; 15(3):275-82. PubMed ID: 9177922
[TBL] [Abstract][Full Text] [Related]
13. Multitarget Therapy for Maintenance Treatment of Lupus Nephritis.
Zhang H; Liu Z; Zhou M; Liu Z; Chen J; Xing C; Lin H; Ni Z; Fu P; Liu F; Chen N; He Y; Liu J; Zeng C; Liu Z
J Am Soc Nephrol; 2017 Dec; 28(12):3671-3678. PubMed ID: 28760751
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive Therapies for the Maintenance Treatment of Proliferative Lupus Nephritis: A Systematic Review and Network Metaanalysis.
Tian SY; Feldman BM; Beyene J; Brown PE; Uleryk EM; Silverman ED
J Rheumatol; 2015 Aug; 42(8):1392-400. PubMed ID: 26077406
[TBL] [Abstract][Full Text] [Related]
15. Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long-term follow-up.
Carette S; Klippel JH; Decker JL; Austin HA; Plotz PH; Steinberg AD; Balow JE
Ann Intern Med; 1983 Jul; 99(1):1-8. PubMed ID: 6344715
[TBL] [Abstract][Full Text] [Related]
16. Renal outcome in patients with lupus nephritis using a steroid-free regimen of monthly intravenous cyclophosphamide: a prospective observational study.
Fischer-Betz R; Chehab G; Sander O; Vordenbäumen S; Voiculescu A; Brinks R; Schneider M
J Rheumatol; 2012 Nov; 39(11):2111-7. PubMed ID: 22984276
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
Arends S; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M; Berden JH;
Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
[TBL] [Abstract][Full Text] [Related]
18. Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts.
Ruiz-Irastorza G; Ugarte A; Saint-Pastou Terrier C; Lazaro E; Iza A; Couzi L; Saenz R; Richez C; Porta S; Blanco P
Autoimmun Rev; 2017 Aug; 16(8):826-832. PubMed ID: 28564619
[TBL] [Abstract][Full Text] [Related]
19. Prednisone and azathioprine compared to prednisone plus low-dose azathioprine and cyclophosphamide in the treatment of diffuse lupus nephritis.
Ginzler E; Diamond H; Guttadauria M; Kaplan D
Arthritis Rheum; 1976; 19(4):693-9. PubMed ID: 782464
[TBL] [Abstract][Full Text] [Related]
20. Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials.
Henderson LK; Masson P; Craig JC; Roberts MA; Flanc RS; Strippoli GF; Webster AC
Am J Kidney Dis; 2013 Jan; 61(1):74-87. PubMed ID: 23182601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
